HomeATRA • NASDAQ
add
Atara Biotherapeutics Inc
Previous close
$7.61
Day range
$6.76 - $7.50
Year range
$5.01 - $18.70
Market cap
40.78M USD
Avg Volume
56.45K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 98.15M | 258.77% |
Operating expense | 38.91M | 298.81% |
Net income | 38.01M | 219.71% |
Net profit margin | 38.73 | 133.37% |
Earnings per share | 3.50 | 160.87% |
EBITDA | 40.60M | 261.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.84M | -70.07% |
Total assets | 62.04M | -62.46% |
Total liabilities | 117.11M | -55.57% |
Total equity | -55.07M | — |
Shares outstanding | 5.96M | — |
Price to book | -0.82 | — |
Return on assets | 113.37% | — |
Return on capital | -241.86% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 38.01M | 219.71% |
Cash from operations | -28.14M | 4.98% |
Cash from investing | 17.20M | 16.86% |
Cash from financing | -250.00K | -101.04% |
Net change in cash | -11.19M | -221.01% |
Free cash flow | -34.17M | -280.39% |
About
Founded
2012
Headquarters
Website
Employees
153
